Potentiation of ligand binding through cooperative effects in monoamine oxidase B. (41/136)

Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. (42/136)

Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration. (43/136)

Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics. (44/136)

Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. (45/136)

Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. (46/136)

The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. (47/136)

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. (48/136)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10